Warren, Richard B, Kristian Reich, Eric L Simpson, Richard Langley, Antonio Costanzo, Hidehisa Saeki, Peter Almgren, Emilia Vacko, Melinda Gooderham, Mette Deleuran, Juan Francisco Silvestre, Stefan Weidinger, and Andrew Blauvelt. 2022. “3 Years of Tralokinumab Treatment Provides Long-Term Disease Control As Demonstrated by Clinically Meaningful Outcomes in Moderate-to-Severe Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine 6 (6):s78. https://doi.org/10.25251/skin.6.supp.78.